114 related articles for article (PubMed ID: 33358999)
1. Saringosterol acetate isolated from Hizikia fusiforme, an edible brown alga, suppressed hepatocellular carcinoma growth and metastasis in a zebrafish xenograft model.
Kim EA; Lee JH; Heo SJ; Jeon YJ
Chem Biol Interact; 2021 Feb; 335():109362. PubMed ID: 33358999
[TBL] [Abstract][Full Text] [Related]
2. 24(R, S)-Saringosterol - From artefact to a biological medical agent.
Vanbrabant K; Van Meel D; Kerksiek A; Friedrichs S; Dubbeldam M; Schepers M; Zhan N; Gutbrod K; Dörmann P; Liu HB; Mulder MT; Vanmierlo T; Lütjohann D
J Steroid Biochem Mol Biol; 2021 Sep; 212():105942. PubMed ID: 34144153
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Obese Zebrafish with Saringosterol Acetate through AMP Activated Protein Kinase Pathway.
Zhou DY; Fu YH; Li FT; Yang D; Wei LN; Yue H; Dai YL; Jeon YJ
Chem Biodivers; 2022 Sep; 19(9):e202200495. PubMed ID: 35856892
[TBL] [Abstract][Full Text] [Related]
4. 24(S)-Saringosterol from edible marine seaweed Sargassum fusiforme is a novel selective LXRβ agonist.
Chen Z; Liu J; Fu Z; Ye C; Zhang R; Song Y; Zhang Y; Li H; Ying H; Liu H
J Agric Food Chem; 2014 Jul; 62(26):6130-7. PubMed ID: 24927286
[TBL] [Abstract][Full Text] [Related]
5. Saringosterol from
Yan Y; Niu Z; Wang B; Zhao S; Sun C; Wu Y; Li Y; Ying H; Liu H
Mar Drugs; 2021 Aug; 19(9):. PubMed ID: 34564147
[TBL] [Abstract][Full Text] [Related]
6. Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer's disease mouse model.
Bogie J; Hoeks C; Schepers M; Tiane A; Cuypers A; Leijten F; Chintapakorn Y; Suttiyut T; Pornpakakul S; Struik D; Kerksiek A; Liu HB; Hellings N; Martinez-Martinez P; Jonker JW; Dewachter I; Sijbrands E; Walter J; Hendriks J; Groen A; Staels B; Lütjohann D; Vanmierlo T; Mulder M
Sci Rep; 2019 Mar; 9(1):4908. PubMed ID: 30894635
[TBL] [Abstract][Full Text] [Related]
7. Anti-Obesity Activity of Saringosterol Isolated from Sargassum muticum (Yendo) Fensholt Extract in 3T3-L1 Cells.
Lee JA; Cho YR; Hong SS; Ahn EK
Phytother Res; 2017 Nov; 31(11):1694-1701. PubMed ID: 28921681
[TBL] [Abstract][Full Text] [Related]
8. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
[TBL] [Abstract][Full Text] [Related]
9. Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing.
Tonon F; Zennaro C; Dapas B; Carraro M; Mariotti M; Grassi G
Int J Pharm; 2016 Dec; 515(1-2):583-591. PubMed ID: 27989824
[TBL] [Abstract][Full Text] [Related]
10. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3.
Gu FM; Li QL; Gao Q; Jiang JH; Huang XY; Pan JF; Fan J; Zhou J
World J Gastroenterol; 2011 Sep; 17(34):3922-32. PubMed ID: 22025881
[TBL] [Abstract][Full Text] [Related]
12. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
Bagi CM; Gebhard DF; Andresen CJ
Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
[TBL] [Abstract][Full Text] [Related]
14. A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel.
Ji X; Shen Y; Sun H; Gao X
Tumour Biol; 2016 Aug; 37(8):10085-96. PubMed ID: 26820129
[TBL] [Abstract][Full Text] [Related]
15. Metformin incombination with curcumin inhibits the growth, metastasis, and angiogenesis of hepatocellular carcinoma in vitro and in vivo.
Zhang HH; Zhang Y; Cheng YN; Gong FL; Cao ZQ; Yu LG; Guo XL
Mol Carcinog; 2018 Jan; 57(1):44-56. PubMed ID: 28833603
[TBL] [Abstract][Full Text] [Related]
16. The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.
Gedaly R; Angulo P; Chen C; Creasy KT; Spear BT; Hundley J; Daily MF; Shah M; Evers BM
Anticancer Res; 2012 Jul; 32(7):2531-6. PubMed ID: 22753710
[TBL] [Abstract][Full Text] [Related]
17. Solanine Inhibits Immune Escape Mediated by Hepatoma Treg Cells via the TGF
Gao J; Ying Y; Wang J; Cui Y
Biomed Res Int; 2020; 2020():9749631. PubMed ID: 33204731
[TBL] [Abstract][Full Text] [Related]
18. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.
Peng R; Zhao GX; Li J; Zhang Y; Shen XZ; Wang JY; Sun JY
World J Gastroenterol; 2016 Mar; 22(12):3341-54. PubMed ID: 27022216
[TBL] [Abstract][Full Text] [Related]
19. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
[TBL] [Abstract][Full Text] [Related]
20. 1β-OH-arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway.
Deng LJ; Lei YH; Quan JY; Li BJ; Zhang DM; Tian HY; Chen Y; Zhang EX; Chen L; Ye WC; Ning WM; Yu LZ; Liu JS
J Ethnopharmacol; 2021 Feb; 266():113443. PubMed ID: 33022344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
